The results describe a new oral formulation of Irinotecan (IRN-SRN) encapsulated into nanoparticles allowing an oral release of the molecule. The company said that the aim of this
Under the agreement, Medicines for Malaria Venture (MMV) will have access to the Pfizer library of novel chemical entities, in order to screen it for compounds that have
With this acquisition, Schwabe will expand its presence in Austria and central & eastern Europe (CEE). Dirk Reischig, chairman and CEO of Dr Willmar Schwabe Pharmaceuticals, said: “We
Charles O’Neill, CEO of Avalon Healthcare, said: “A direct relationship with the Lee Memorial Health System (LMHS) provides an important first step in Avalon’s strategy to become an
As the newest member of Datatrak’s CRO Connect Program, Keypoint is able to expand its electronic data capture (EDC) capabilities and empower its staff to more efficiently manage
Dr. Smith is a distinguished clinician and research scientist, who has made major contributions to the Canadian cardiology and medical communities and, in recognition of his outstanding achievements,
Eli Lilly and Company has reported a net income of $1.31 billion, or $1.20 per share, for the first quarter of 2009, an increase of 23%, compared to
Sanofi Pasteur, the vaccines division of Sanofi-Aventis Group, has initiated clinical studies of its investigational tetravalent dengue vaccine in Singapore and Vietnam. With these studies, Sanofi Pasteur is
Par Pharmaceutical Companies, a developer of generic drugs and branded pharmaceuticals, has entered into a settlement agreement with Reliant Pharmaceuticals, a subsidiary of GlaxoSmithKline, that resolves patent litigation
BioMarin Pharmaceutical has initiated a Phase I/II clinical trial for BMN-110 or N-acetylgalactosamine 6-sulfatase, intended for the treatment of the lysosomal storage disorder mucopolysaccharidosis type IVA, or Morquio
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.